179 related articles for article (PubMed ID: 25140889)
1. 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
Spencer AJ; Furze J; Honeycutt JD; Calvert A; Saurya S; Colloca S; Wyllie DH; Gilbert SC; Bregu M; Cottingham MG; Hill AV
PLoS One; 2014; 9(8):e105520. PubMed ID: 25140889
[TBL] [Abstract][Full Text] [Related]
2. An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.
Ragonnaud E; Andersson AM; Pedersen AE; Laursen H; Holst PJ
Vaccine; 2016 Apr; 34(18):2147-56. PubMed ID: 27004934
[TBL] [Abstract][Full Text] [Related]
3. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
Zhao Y; Croft M
Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
[TBL] [Abstract][Full Text] [Related]
4. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.
Kanagavelu S; Termini JM; Gupta S; Raffa FN; Fuller KA; Rivas Y; Philip S; Kornbluth RS; Stone GW
PLoS One; 2014; 9(2):e90100. PubMed ID: 24587225
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
7. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
Harrison JM; Bertram EM; Boyle DB; Coupar BE; Ranasinghe C; Ramshaw IA
Vaccine; 2006 Nov; 24(47-48):6867-74. PubMed ID: 17050052
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.
Kudo-Saito C; Hodge JW; Kwak H; Kim-Schulze S; Schlom J; Kaufman HL
Vaccine; 2006 Jun; 24(23):4975-86. PubMed ID: 16621183
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner.
Srivastava AK; Sharma RK; Yolcu ES; Ulker V; MacLeod K; Dinc G; Shirwan H
PLoS One; 2012; 7(11):e48463. PubMed ID: 23144888
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
Moraes TJ; Lin GH; Wen T; Watts TH
Vaccine; 2011 Aug; 29(37):6301-12. PubMed ID: 21704101
[TBL] [Abstract][Full Text] [Related]
11. Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.
Lin GH; Edele F; Mbanwi AN; Wortzman ME; Snell LM; Vidric M; Roth K; Hauser AE; Watts TH
Eur J Immunol; 2012 Nov; 42(11):2861-74. PubMed ID: 22886791
[TBL] [Abstract][Full Text] [Related]
12. CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects.
Park HM; Sohn HJ; Kim YJ; Cho HI; Kim TG
Vaccine; 2014 Dec; 32(51):6919-6926. PubMed ID: 25444817
[TBL] [Abstract][Full Text] [Related]
13. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
[TBL] [Abstract][Full Text] [Related]
15. Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.
Yan X; Johnson BD; Orentas RJ
Immunology; 2004 May; 112(1):105-16. PubMed ID: 15096190
[TBL] [Abstract][Full Text] [Related]
16. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
Pulle G; Vidric M; Watts TH
J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029
[TBL] [Abstract][Full Text] [Related]
17. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates.
Padte NN; Boente-Carrera M; Andrews CD; McManus J; Grasperge BF; Gettie A; Coelho-dos-Reis JG; Li X; Wu D; Bruder JT; Sedegah M; Patterson N; Richie TL; Wong CH; Ho DD; Vasan S; Tsuji M
PLoS One; 2013; 8(10):e78407. PubMed ID: 24205224
[TBL] [Abstract][Full Text] [Related]
18. Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.
Kim YM; Kim HK; Kim HJ; Lee HW; Ju SA; Choi BK; Kwon BS; Kim BS; Kim JB; Lim YT; Yoon S
Exp Mol Med; 2009 Dec; 41(12):896-911. PubMed ID: 19745604
[TBL] [Abstract][Full Text] [Related]
19. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.
Dawicki W; Watts TH
Eur J Immunol; 2004 Mar; 34(3):743-751. PubMed ID: 14991604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
